Compare Eli Lilly And Co (LLY) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs PepsiCo, Inc. — how do they compare? Eli Lilly And Co trades at $1,178.99 (market cap $1.04T), while PepsiCo, Inc. trades at $126.15 (market cap $174.89B). The key difference: Eli Lilly And Co is far larger — about 5.9× PepsiCo, Inc.'s market cap, and PepsiCo, Inc. pays the higher dividend (4.61%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and PepsiCo, Inc. for 107 Days on average.
| LLY | PEP | |
|---|---|---|
Market Cap | $1.04T | $174.89B |
Volume | 3,064,878 | 23,968,864 |
Sector | Health | Consumer Staples |
52-Week High | $1.28K | $170.44 |
52-Week Low | $799.57 | $123.64 |
Typical Hold Time | 93 Days | 107 Days |
Enterprise Value | $1.09T | $215.61B |
Dividend Yield | 0.59% | 4.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.
PepsiCo (PEP) trades at $125.97, up 1.88% today, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q3 2026 EPS of $2.34 exceeding the $2.29 estimate. Revenue grew to $93.93B in 2025, though net income margin dipped to 8.77%. Analysts maintain a consensus price target of $146.77, implying significant upside. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, while institutional holdings saw mixed adjustments.
The outlook for PEP is cautiously optimistic, driven by earnings momentum and a reasonable P/E of 16.14. Risks include competitive pressures and sensitivity to consumer spending. The stock offers a dividend yield near 4%, supporting income-focused investors. Upside potential exists if North American performance improves, but volatility may persist amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
